The company has launched its product, a generic version of Novartis Pharma AG#39;s Exjade tablets for oral suspension, after getting the nod from the United States Food and Drug Administration (USFDA), Dr Reddy#39;s Labs said in a filing to the BSE.from Moneycontrol Business News https://ift.tt/34XkvDF
No comments:
Post a Comment